Literature DB >> 8801286

Analysis of the human serological immune response to a variable region of the attachment (G) protein of respiratory syncytial virus during primary infection.

P A Cane1, H M Thomas, A F Simpson, J E Evans, C A Hart, C R Pringle.   

Abstract

The serum antibody responses of babies to the variable carboxy-terminal region of the attachment (G) protein of respiratory syncytial virus (RSV) have been analysed using paired acute and convalescent sera from infants experiencing their first RSV infection with viruses of known genotype. The variable 84-85 carboxy-terminal amino acids of the G protein of six recent isolates of group A RSV were expressed in Escherichia coli as fusion proteins with glutahione S-transferase. About half the infants developed antibodies which recognised these fusion proteins. The patterns of response obtained in enzyme linked immunosorbant assays and immunoblotting assays were closely related to the infecting genotype.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8801286     DOI: 10.1002/(SICI)1096-9071(199603)48:3<253::AID-JMV7>3.0.CO;2-7

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  20 in total

1.  Immunological responses to respiratory syncytial virus infection in infancy.

Authors:  R L Smyth; J N Fletcher; H M Thomas; C A Hart
Journal:  Arch Dis Child       Date:  1997-03       Impact factor: 3.791

2.  Antibody response to the central unglycosylated region of the respiratory syncytial virus attachment protein in mice.

Authors:  Yoshihiko Murata; Seana C Catherman
Journal:  Vaccine       Date:  2012-06-19       Impact factor: 3.641

Review 3.  Respiratory syncytial virus genetic and antigenic diversity.

Authors:  W M Sullender
Journal:  Clin Microbiol Rev       Date:  2000-01       Impact factor: 26.132

4.  Multiplex assay for detection of strain-specific antibodies against the two variable regions of the G protein of respiratory syncytial virus.

Authors:  Les P Jones; Hao-Qiang Zheng; Ruth A Karron; Teresa C T Peret; Cecelia Tsou; Larry J Anderson
Journal:  Clin Diagn Lab Immunol       Date:  2002-05

5.  Identification of multiple protective epitopes (protectopes) in the central conserved domain of a prototype human respiratory syncytial virus G protein.

Authors:  H Plotnicky-Gilquin; L Goetsch; T Huss; T Champion; A Beck; J F Haeuw; T N Nguyen; J Y Bonnefoy; N Corvaïa; U F Power
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

6.  Humoral response to the central unglycosylated region of the respiratory syncytial virus attachment protein.

Authors:  Yoshihiko Murata; Paula M Lightfoote; Jamie N Biear; Ann R Falsey; Edward E Walsh
Journal:  Vaccine       Date:  2010-07-23       Impact factor: 3.641

7.  Respiratory syncytial virus genotypes and disease severity among children in hospital.

Authors:  J N Fletcher; R L Smyth; H M Thomas; D Ashby; C A Hart
Journal:  Arch Dis Child       Date:  1997-12       Impact factor: 3.791

8.  Influence of respiratory syncytial virus strain differences on pathogenesis and immunity.

Authors:  José A Melero; Martin L Moore
Journal:  Curr Top Microbiol Immunol       Date:  2013       Impact factor: 4.291

9.  Neonatal immunization with respiratory syncytial virus glycoprotein fragment induces protective immunity in the presence of maternal antibodies in mice.

Authors:  Youran Noh; Byoung-Shik Shim; In Su Cheon; Semi Rho; Hee Joo Kim; Youngjoo Choi; Chang-Yuil Kang; Jun Chang; Man Ki Song; Jae-Ouk Kim
Journal:  Viral Immunol       Date:  2013-07-19       Impact factor: 2.257

10.  Positive selection results in frequent reversible amino acid replacements in the G protein gene of human respiratory syncytial virus.

Authors:  Viviane F Botosso; Paolo M de A Zanotto; Mirthes Ueda; Eurico Arruda; Alfredo E Gilio; Sandra E Vieira; Klaus E Stewien; Teresa C T Peret; Leda F Jamal; Maria I de M C Pardini; João R R Pinho; Eduardo Massad; Osvaldo A Sant'anna; Eddie C Holmes; Edison L Durigon
Journal:  PLoS Pathog       Date:  2009-01-02       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.